Strategic Fund Product Prices. Antileishmaniasis Medicines (valid until 31-Dec-2020)

 Antileishmaniasis Medicines

 Antileishmaniasis Medicines (valid until 31-Dec-2020) 

Long Term Agreement 

1. The prices published reflect the price of the product
2. For budgeting purposes PAHO suggests Member States add an additional 15-25% to reflect the costs of shipping, insurance, 3% contribution to the SF capital account and the 1.25% PAHO fee.
3. Medicines not included in this list, can be purchase individually upon request by Member States. Prices and lead-time will depend on the product availability at the time of the request.
4. Questions should be directed to strategicfund@paho.org.
5. AMPHOTERICIN LIPOSOMAL access price only for treatment of Leishmaniasis Visceral, and Cryptococcal Meningitis.
For further information on the PAHO Strategic Fund please visits www.paho.org/strategicfund.

 

Download (135.37 KB)